Synonymous mutations that regulate translation speed might play a non-negligible role in liver cancer development

BMC Cancer. 2021 Apr 9;21(1):388. doi: 10.1186/s12885-021-08131-w.

Abstract

Background: Synonymous mutations do not change the protein sequences. Automatically, they have been regarded as neutral events and are ignored in the mutation-based cancer studies. However, synonymous mutations will change the codon optimality, resulting in altered translational velocity.

Methods: We fully utilized the transcriptome and translatome of liver cancer and normal tissue from ten patients. We profiled the mutation spectrum and examined the effect of synonymous mutations on translational velocity.

Results: Synonymous mutations that increase the codon optimality significantly enhanced the translational velocity, and were enriched in oncogenes. Meanwhile, synonymous mutations decreasing codon optimality slowed down translation, and were enriched in tumor suppressor genes. These synonymous mutations significantly contributed to the translational changes in tumor samples compared to normal samples.

Conclusions: Synonymous mutations might play a role in liver cancer development by altering codon optimality and translational velocity. Synonymous mutations should no longer be ignored in the genome-wide studies.

Keywords: Codon usage; Gene expression; Liver cancer; Synonymous mutations; Translation.

MeSH terms

  • Alleles
  • Biomarkers, Tumor*
  • Cell Transformation, Neoplastic / genetics*
  • Cell Transformation, Neoplastic / metabolism
  • Chromosome Mapping
  • Codon
  • Computational Biology / methods
  • Databases, Genetic
  • Disease Susceptibility*
  • Genes, Tumor Suppressor
  • Humans
  • Liver Neoplasms / etiology*
  • Liver Neoplasms / metabolism
  • Oncogenes
  • Polymorphism, Single Nucleotide
  • Protein Biosynthesis*
  • Silent Mutation*

Substances

  • Biomarkers, Tumor
  • Codon